Literature DB >> 17199055

Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.

Stephen M Strakowski1, Melissa P DelBello, David E Fleck, Caleb M Adler, Robert M Anthenelli, Paul E Keck, Lesley M Arnold, Jennifer Amicone.   

Abstract

CONTEXT: Cannabis use disorders commonly co-occur in bipolar disorder; however, the effects of cannabis abuse on outcome have been minimally studied.
OBJECTIVE: To identify how the sequence of the onsets of a cannabis use disorder and bipolar disorder is associated with the subsequent course of each condition.
DESIGN: Inception cohort.
SETTING: Academic medical center. PATIENTS: Patients (N = 144) were studied who met criteria for bipolar I disorder (manic or mixed), were 12 to 45 years old, and had no previous hospitalizations and minimal previous treatment. Patients were followed up for up to 5 years and included 33 in whom the onset of a cannabis use disorder preceded the onset of bipolar disorder (cannabis first), 36 in whom bipolar disorder onset preceded the onset of cannabis abuse (bipolar first), and 75 with bipolar disorder only. MAIN OUTCOME MEASURES: Symptomatic recovery and recurrence of both conditions and percentage of follow-up time with affective and cannabis use disorder symptoms.
RESULTS: The cannabis first group exhibited better recovery than the other groups, although when adjusted for potential mediator variables these results did not persist. Cannabis use was associated with more time in affective episodes and with rapid cycling. Most cannabis use disorders remitted immediately after hospitalization, followed by rapid rates of recurrence.
CONCLUSIONS: The effects of the sequence of onsets of bipolar and cannabis use disorders were less pronounced than observed in co-occurring alcohol and bipolar disorders. Aggressive drug abuse treatment immediately after a first psychiatric hospitalization might decrease rates of recurrence and new cases of cannabis use disorder in the course of bipolar disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17199055     DOI: 10.1001/archpsyc.64.1.57

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  36 in total

Review 1.  Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-24       Impact factor: 5.067

Review 2.  Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Authors:  Simone Tambaro; Marco Bortolato
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

Review 3.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

4.  The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.

Authors:  Melissa A Weibell; Wenche Ten Velden Hegelstad; Bjørn Auestad; Jørgen Bramness; Julie Evensen; Ulrik Haahr; Inge Joa; Jan Olav Johannessen; Tor Ketil Larsen; Ingrid Melle; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum; Thomas McGlashan; Patrick McGorry; Svein Friis
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 5.  The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations.

Authors:  Jaimee L Heffner; Jeffrey R Strawn; Melissa P DelBello; Stephen M Strakowski; Robert M Anthenelli
Journal:  Bipolar Disord       Date:  2011 Aug-Sep       Impact factor: 6.744

6.  Risk and protective factors associated with substance use disorders in adolescents with first-episode mania.

Authors:  Jacob R Stephens; Jaimee L Heffner; Caleb M Adler; Thomas J Blom; Robert M Anthenelli; David E Fleck; Jeffrey A Welge; Stephen M Strakowski; Melissa P DelBello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-05-10       Impact factor: 8.829

7.  Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder.

Authors:  Raphael J Braga; Katherine E Burdick; Pamela Derosse; Anil K Malhotra
Journal:  Psychiatry Res       Date:  2012-07-18       Impact factor: 3.222

8.  The influence of comorbid disorders on the episodicity of bipolar disorder in youth.

Authors:  S Yen; R Stout; H Hower; M A Killam; L M Weinstock; D R Topor; D P Dickstein; J I Hunt; M K Gill; T R Goldstein; B I Goldstein; N D Ryan; M Strober; R Sala; D A Axelson; B Birmaher; M B Keller
Journal:  Acta Psychiatr Scand       Date:  2015-10-17       Impact factor: 6.392

9.  Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  Michael J Ostacher; Roy H Perlis; Andrew A Nierenberg; Joseph Calabrese; Jonathan P Stange; Ihsan Salloum; Roger D Weiss; Gary S Sachs
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

10.  Difficulties in emotional regulation and substance use disorders: a controlled family study of bipolar adolescents.

Authors:  Timothy E Wilens; MaryKate Martelon; Jesse P Anderson; Rachel Shelley-Abrahamson; Joseph Biederman
Journal:  Drug Alcohol Depend       Date:  2013-02-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.